Wilmington, Delaware, United States, Transparency Market Research, Inc. , Oct. 22, 2024 (GLOBE NEWSWIRE) -- The hemostatic agents industry (Industrie für blutstillende Mittel) was worth US$ 2.6 ...

Results from a genome-wide association study indicate blood clot factors may contribute to the cause of migraine with aura. Although migraineurs who suffer from MA—or flashing lights, blind spots, or ...

A hemostatic powder, TC-325 (Hemospray), worked as well as standard treatment for endoscopic control of acute bleeds from nonvariceal upper gastrointestinal lesions, a randomized trial found. In the ...

Please provide your email address to receive an email when new articles are posted on . A Brooklyn-based biotech firm has announced successful completion of the first phase of a preclinical study ...

A novel hemostatic sealant based on the in situ gel formation of gelatin catalyzed by thrombin and crosslinked by transglutaminase was designed. The aim of this study was to investigate the efficacy ...

Uncontrolled bleeding is still the number one preventable cause of death in combat. That hasn’t changed. Tourniquets changed the game. Hemostatic gauze like QuikClot Combat Gauze changed it again. Now ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted 510(k) clearance to a plant-based, hemostatic gel to treat moderate to severe bleeding, ...

NEW ORLEANS -- There is still hope that recombinant factor VIIa (rFVIIa) may be a good hemostatic treatment for acute intracerebral hemorrhage (ICH) under the right circumstances -- just not the way ...

NEW ORLEANS, LA—Recombinant factor VIIa slowed hematoma growth in patients with a spontaneous intracerebral hemorrhage (ICH) when administered within 2 hours of onset, but treatment significantly ...

A next-generation hemostatic powder that stops bleeding one second after being applied has been developed. It is expected to greatly help combatants who die from excessive bleeding in war. KAIST ...